http://www.nasdaq.com/symbol/unis $4.08 We are a designer,...

http://www.nasdaq.com/symbol/unis

$4.08

We are a designer, manufacturer and supplier of innovative injectable drug delivery systems that can enhance and differentiate the injectable drugs, biologics and vaccines, or collectively injectable therapies, of our pharmaceutical and biotechnology customers. We have a broad portfolio of proprietary product platforms, including pre-filled syringes, drug reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and other novel injectable drug delivery systems. Products within each platform are highly differentiated from competitors’ products with a series of innovative features designed to optimize the safe, simple and convenient administration of an injectable therapy.

___________________________________________

But what makes Medigard’s product any different to what’s already on the market?

“It’s revolutionary in terms of the technology as we use a vacuum to draw our needle back,” says Emery.

“It will be price competitive and there’s no aerosoling. It’s better than most because it doesn’t have a fixed needle and so people can have interchangeable needles. The good news is that our syringe and blood collection device have been tested and trialled in real hospitals in the United States and almost without exception the nurses and clinicians say that if it was on the market now, they would buy it.